Understand the source comparison
Glow Stack 2026: Component Comparison
Thymalin Thymic peptide. Normalizes T-regulatory cell ratios, reduces dermal inflammation (IL-6, TNF-alpha suppression) 5–10mg every 3–4 days Subcutaneous injection Yes. Bacteriostatic water 28 days at 2–8°C MK-677 Ghrelin receptor agonist. Stimulates GH pulse
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Thymalin
- Thymic peptide. Normalizes T-regulatory cell ratios, reduces dermal inflammation (IL-6, TNF-alpha suppression)
- 5–10mg every 3–4 days
- Subcutaneous injection
- Yes. Bacteriostatic water
- 28 days at 2–8°C
- MK-677
- Ghrelin receptor agonist. Stimulates GH pulses, raises IGF-1 60–90%, upregulates COL1A1/COL3A1 expression
- 12.5–25mg daily (evening)
- Oral
- No. Arrives as powder for oral suspension
- Stable as dry powder; mix fresh daily
- Cerebrolysin
- Neurotrophic peptide concentrate (BDNF, GDNF, CNTF). Promotes angiogenesis, increases dermal capillary density
- 5–10mL, 2–3 times weekly
- Intramuscular or IV
- No. Ships pre-mixed in ampules
- Refrigerate immediately; use within labeled expiration
- Dihexa
- HGF pathway amplifier. Increases BDNF 10-fold, triggers MSC differentiation into fibroblasts
- 1–3mg, 2–4 times weekly
- Subcutaneous or nasal
- 14 days at 2–8°C